Secondary Stock OfferingsBy The Online Investor Staff, updated Wed., May. 27, 11:55 AM
|This Slide: #2 of 25|
Slide #2. Viela Bio, Inc — Secondary Offering
Viela Bio, Inc (NASDAQ:VIE)
Secondary Offering Details:
Viela Bio, Inc. (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced that it intends to offer and sell, subject to market and other conditions, 3,000,000 shares of its common stock in an underwritten public offering. In addition, certain selling stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock from the selling stockholders.
Viela Bio operates as a clinical-stage biotechnology company. Co. develops and commercializes therapeutics and medicines for the treatment of patients with autoimmune and severe inflammatory diseases. Co. serves patients worldwide.
VIE SEC Filing Email Alerts Service
Open the VIE Page at The Online Investor »
Strong Buy (3.90 out of 4)
(ranked higher than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite